Navigation Links
UC Davis researchers find molecule that targets brain tumors
Date:12/29/2008

(SACRAMENTO, Calif.) UC Davis Cancer Center researchers report today the discovery of a molecule that targets glioblastoma, a highly deadly form of cancer. The finding, which is published in the January 2009 issue of the European Journal of Nuclear Medicine and Molecular Imaging, provides hope for effectively treating an incurable cancer.

Glioblastoma is the most common and aggressive type of primary brain tumor in adults. It is marked by tumors with irregular shapes and poorly defined borders that rapidly invade neighboring tissues, making them difficult to remove surgically.

"These brain tumors are currently treated with surgery to remove as much of the tumor as possible followed by radiation to kill cancer cells left behind and systemic chemotherapy to prevent spread to nearby tissues," said Kit Lam, senior author of the study and UC Davis chief of hematology and oncology. "It is unfortunate that this approach does not extend survival significantly. Most patients survive less than one year."

To find new options for treating the disease, Lam and his colleagues began searching for a molecule that could be injected into a patient's bloodstream and deliver high concentrations of medication or radionuclides directly to brain tumor cells while sparing normal tissues. Through their study, they identified a molecule called LXY1 that binds with high specificity to a particular cell-surface protein called alpha-3 integrin, which is overexpressed on cancer cells.

They also tested the molecule's ability to target brain cancer by implanting human glioblastoma cells both beneath the skin and in the brains of mice. The researchers injected the mice with a radiolabeled version of LXY1 and, using near-infrared fluorescence imaging, showed that the molecule did preferentially bind to human glioblastoma cells in both locations.

"This outcome gives us great hope that we will be able to deliver targeted therapies to treat gl
'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis - Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC Davis discovery offers hope for treating kidney cancer
2. UC Davis team refines cancer treatments to reduce potential nerve damage
3. UC Davis researchers exploring gene therapy to fight AIDS
4. UC Davis researchers discover Achilles heel in pancreatic cancer
5. UC Davis researchers discover a key to aggressive breast cancer
6. UC Davis chemical ecologist wins major award
7. UC Davis researchers discover new drug target for inflammatory disease
8. UC Davis researchers define characteristics, treatment options for XXYY syndrome
9. UC Davis researcher leads climate-change discovery
10. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
11. UC Davis researchers discover how HIV turns food-poisoning into lethal infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... The fate of mature T lymphocytes might be a lot ... Center for Allergy and Immunology (RCAI) in Japan and La ... shows for the first time that mature CD4+ helper T ... and gain killing functions. The findings are reported ...
... one of the basics of neurobiology on its head ... already differentiated neuron into another within the brain. The ... maybe the brain is not as immutable as we always ... one can reprogram the identity of one neuronal class into ...
... extensive genomic study of the childhood cancer neuroblastoma ... forms of this disease. Contrary to expectations, the ... would suggest new targets for neuroblastoma treatment. Instead, ... how neuroblastoma tumors evolve in response to medicine ...
Cached Biology News:Mature T cells can switch function to better tackle infection 2Researchers turn one form of neuron into another in the brain 2Researchers turn one form of neuron into another in the brain 3Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets 2
(Date:12/17/2014)... 2014 This report is a ... industry. For an overview analysis, the report introduces ... chain structure, industry overview, policy analysis, and news ... has witnessed rapid development with key manufacturers ... This report mentions quartz tubing upstream raw materials ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic disease, today announced the next step in its ... bio-analytics solutions provider with the naming of current Chief ... Chief Executive Officer, while current Chairman of the Board ... serve as Chairman. These changes are effective January 1, ...
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... Nerve Repair Discussed at American Society of Plastic Surgeons ... ... With the debut of NBC,s,"Bionic Woman," the notion of a bionic ... is getting closer to reality,as reconstructive plastic surgeons perform quality-of-life-enhancing,peripheral nerve ...
... 26 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: "HBP") today ... During the 2007 fiscal year, the Company continued ... pre-clinical (L-DOS47),development programs. The following are selected highlights during ... - Topical Interferon Alpha-2b, ...
... the first to demonstrate how an electron,s spin can ... engineers from the University of Delaware and Cambridge NanoTech ... a marathon distance in the world of microelectronics-- through ... silicon--the workhorse material of present-day electronics--now can be harnessed ...
Cached Biology Technology:Creating the Bionic Woman: Making Nerves Spring Back to Life 2Creating the Bionic Woman: Making Nerves Spring Back to Life 3Helix BioPharma Corp. announces fiscal 2007 results 2Helix BioPharma Corp. announces fiscal 2007 results 3Helix BioPharma Corp. announces fiscal 2007 results 4Helix BioPharma Corp. announces fiscal 2007 results 5Helix BioPharma Corp. announces fiscal 2007 results 6Helix BioPharma Corp. announces fiscal 2007 results 7Helix BioPharma Corp. announces fiscal 2007 results 8Helix BioPharma Corp. announces fiscal 2007 results 9Helix BioPharma Corp. announces fiscal 2007 results 10Helix BioPharma Corp. announces fiscal 2007 results 11Helix BioPharma Corp. announces fiscal 2007 results 12UD researchers race ahead with latest spintronics achievement 2